EDGAR Filing Documents for 0001415889-15-001364

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001415889-15-001364

Filing Date

2015-04-15

Accepted

2015-04-15 17:20:12

Documents

Period of Report

2014-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10K	ecte10k_12312014.htm	10-K	1402929
2	LETTER OF AGREEMENT	ex10-39.htm	EX-10.39	71119
3	SECURITIES PURCHASE AGREEMENT DATED DECEMBER 18, 2014, BY AND BETWEEN THE COMPAN	ex10-40.htm	EX-10.40	304750
4	AMENDMENT TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BETWEEN ECHO T	ex10-43.htm	EX-10.43	24869
5	SUBSIDIARIES OF THE COMPANY.	ex21-1.htm	EX-21.1	2766
6	CONSENT OF BDO USA LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.	ex23-1.htm	EX-23.1	2583
7	CONSENT OF WOLF & COMPANY, P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.	ex23-2.htm	EX-23.2	2594
8	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14 (A) UNDER T	ex31-1.htm	EX-31.1	8749
9	CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14 (A) UNDER T	ex31-2.htm	EX-31.2	9090
10	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,	ex32-1.htm	EX-32.1	4521
11	CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,	ex32-2.htm	EX-32.2	4955
12		ecte10k_123120140.jpg	GRAPHIC	19990
	Complete submission text file	0001415889-15-001364.txt		6740830

Data Files

Seq	Document	Type	Size
13	ecte-20141231.xml	EX-101.INS	757815
14	ecte-20141231.xsd	EX-101.SCH	55620
15	ecte-20141231_cal.xml	EX-101.CAL	51884
16	ecte-20141231_def.xml	EX-101.DEF	135319
17	ecte-20141231_lab.xml	EX-101.LAB	353402
18	ecte-20141231_pre.xml	EX-101.PRE	260399

Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830

Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 732-549-0919

Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)